8950773

Source:http://linkedlifedata.com/resource/pubmed/id/8950773

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019080, umls-concept:C0035648, umls-concept:C0205178, umls-concept:C1861172, umls-concept:C2709058
pubmed:issue	5
pubmed:dateCreated	1997-3-24
pubmed:abstractText	Identification of risk factors for bleeding and prospective evaluation of two bleeding risk scores in the treatment of acute venous thromboembolism.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7608063
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Acenocoumarol, http://linkedlifedata.com/resource/pubmed/chemical/Chondroitin Sulfates, http://linkedlifedata.com/resource/pubmed/chemical/Dermatan Sulfate, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Heparitin Sulfate, http://linkedlifedata.com/resource/pubmed/chemical/danaproid
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0340-6245
pubmed:author	pubmed-author:BangaJ DJD, pubmed-author:BrouwerC BCB, pubmed-author:HartH CHC, pubmed-author:MeuwissenO JOJ, pubmed-author:NieuwenhuisH KHK, pubmed-author:SixmaJ JJJ, pubmed-author:WestelJ FJF, pubmed-author:de ValkH WHW, pubmed-author:van der GraafYY
pubmed:issnType	Print
pubmed:volume	76
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	682-8
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:8950773-Acenocoumarol, pubmed-meshheading:8950773-Acute Disease, pubmed-meshheading:8950773-Adult, pubmed-meshheading:8950773-Aged, pubmed-meshheading:8950773-Body Surface Area, pubmed-meshheading:8950773-Chondroitin Sulfates, pubmed-meshheading:8950773-Comorbidity, pubmed-meshheading:8950773-Dermatan Sulfate, pubmed-meshheading:8950773-Drug Combinations, pubmed-meshheading:8950773-Female, pubmed-meshheading:8950773-Fibrinolytic Agents, pubmed-meshheading:8950773-Hemorrhage, pubmed-meshheading:8950773-Heparin, pubmed-meshheading:8950773-Heparitin Sulfate, pubmed-meshheading:8950773-Humans, pubmed-meshheading:8950773-Male, pubmed-meshheading:8950773-Middle Aged, pubmed-meshheading:8950773-Neoplasms, pubmed-meshheading:8950773-Odds Ratio, pubmed-meshheading:8950773-Prospective Studies, pubmed-meshheading:8950773-Risk Factors, pubmed-meshheading:8950773-Single-Blind Method, pubmed-meshheading:8950773-Thromboembolism, pubmed-meshheading:8950773-Thrombolytic Therapy
pubmed:year	1996
pubmed:articleTitle	Risk factors for bleeding during treatment of acute venous thromboembolism.
pubmed:affiliation	Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Multicenter Study